CABERGOLINE VERSUS COASTING IN THE PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME AND ASSISTED REPRODUCTIVE TECHNOLOGIES OUTCOME IN HIGH RISK PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SOHRABVAND F.; ANSARIPOUR SOHEYLA; BAGHERI MARYAM; SHARIAT MAMAK; JAFARABADI M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Fertility & Sterility Year:2009 | Volume:3 | Issue:1 Page(s): 35-40

Download Full-Text

View:

377

Download:

275

Cites:

Information Journal Paper

Title

CABERGOLINE VERSUS COASTING IN THE PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME AND ASSISTED REPRODUCTIVE TECHNOLOGIES OUTCOME IN HIGH RISK PATIENTS

Author(s)

Keywords

CABERGOLINE

COASTING

OVARIAN HYPERSTIMULATION SYNDROME

PREVENTION

Abstract

Background: COASTING is the most common method used in the PREVENTION of OVARIAN HYPERSTIMULATION SYNDROME (OHSS) acting through vascular endothelial growth factor (VEGF) reduction. However, the pregnancy rate is reported to fall with COASTING when it takes more than three days. Recently low dose CABERGOLINE, a selective D2 dopamine receptor agonist has been proven to selectively reduce vascular permeability without affecting angiogenesis and seems to be able to decrease the rate of OHSS without affecting pregnancy rate.Materials and Methods: This clinical trial was performed on 60 women in assisted reproductive technologies (ART) cycles at risk of OHSS, having at least 20 follicles in their ovaries (mostly£14mm) and a serum estradiol level³3000pg/mL. Patients were divided into two equal groups. In group A, oral CABERGOLINE 0.5 mg/day was given for seven days after hCG administration; while in group B gonadotropin administration was halted until serum estradiol levels reached less than 3000pg/mL before hCG administration. The main outcome measurements compared were rates of pregnancy and severity of OHSS.Results: Total number of oocytes, metaphase II oocytes, fertilization and clinical pregnancy rates were higher in group A (p<0.05). Severe OHSS was not found in either group. Moderate OHSS was seen in one subject in the CABERGOLINE group versus seven in the COASTING group.Conclusion: CABERGOLINE seems to be a safe drug for PREVENTION of moderate-severe OHSS.

Cites

THE HIGHER RESPONSE OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ANGIOTENSIN-II TO HUMAN CHORIONIC GONADOTROPIN IN WOMEN WITH POLYCYSTIC OVARY SYNDROME

References

No record.

Cite

APA: Copy

SOHRABVAND, F., ANSARIPOUR, SOHEYLA, BAGHERI, MARYAM, SHARIAT, MAMAK, & JAFARABADI, M.. (2009). CABERGOLINE VERSUS COASTING IN THE PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME AND ASSISTED REPRODUCTIVE TECHNOLOGIES OUTCOME IN HIGH RISK PATIENTS. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, 3(1), 35-40. SID. https://sid.ir/paper/304463/en

Vancouver: Copy

SOHRABVAND F., ANSARIPOUR SOHEYLA, BAGHERI MARYAM, SHARIAT MAMAK, JAFARABADI M.. CABERGOLINE VERSUS COASTING IN THE PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME AND ASSISTED REPRODUCTIVE TECHNOLOGIES OUTCOME IN HIGH RISK PATIENTS. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY[Internet]. 2009;3(1):35-40. Available from: https://sid.ir/paper/304463/en

IEEE: Copy

F. SOHRABVAND, SOHEYLA ANSARIPOUR, MARYAM BAGHERI, MAMAK SHARIAT, and M. JAFARABADI, “CABERGOLINE VERSUS COASTING IN THE PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME AND ASSISTED REPRODUCTIVE TECHNOLOGIES OUTCOME IN HIGH RISK PATIENTS,” INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, vol. 3, no. 1, pp. 35–40, 2009, [Online]. Available: https://sid.ir/paper/304463/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops